EX-10.2
from 8-K
18 pages
[***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Is Omitted Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. Sublicense Agreement by and Among Pfizer Ireland Pharmaceuticals, Biohaven Pharmaceutical Holding Company Ltd., Bioshin Ltd., and Biohaven Pharmaceutical Ireland Dac Dated November 9, 2021 Sublicense Agreement
12/34/56
EX-10.1
from 8-K
71 pages
[***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Is Omitted Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. Collaboration and License Agreement by and Among Pfizer Ireland Pharmaceuticals, Biohaven Pharmaceutical Holding Company Ltd., Biohaven Pharmaceutical Ireland Dac, and Bioshin Ltd. Dated November 9, 2021
12/34/56
EX-10.1
from 10-Q
147 pages
Financing Agreement Dated as of August 7, 2020 as Amended by That Certain Amendment No. 1 to Financing Agreement Dated as of March 1, 2021 and That Certain Amendment No. 2 to Financing Agreement Dated as of September 30, 2021 Among Biohaven Pharmaceutical Holding Company Ltd. and Biohaven Pharmaceuticals, Inc., as Borrowers, the Guarantors From Time to Time Party Hereto, as Guarantors, Various Lenders From Time to Time Party Hereto, and Sixth Street Specialty Lending, Inc., as Administrative Agent US-Docs\125962273.9 Confidential Treatment Has Been Requested for Portions of This Exhibit. the Copy Filed Herewith Omits the Information Subject to a Confidentiality Request. Omissions Are Designated [***]. a Complete Version of This Exhibit Has Been Filed Separately With the Securities and Exchange Commission
12/34/56
EX-10.1
from 10-K
154 pages
Financing Agreement Dated as of August 7, 2020 as Amended by That Certain Amendment No. 1 to Financing Agreement Dated as of March 1, 2021 Among Biohaven Pharmaceutical Holding Company Ltd. and Biohaven Pharmaceuticals, Inc., as Borrowers, the Guarantors From Time to Time Party Hereto, as Guarantors, Various Lenders From Time to Time Party Hereto, and Sixth Street Specialty Lending, Inc., as Administrative Agent Confidential Treatment Has Been Requested for Portions of This Exhibit. the Copy Filed Herewith Omits the Information Subject to a Confidentiality Request. Omissions Are Designated [***]. a Complete Version of This Exhibit Has Been Filed Separately With the Securities and Exchange Commission
12/34/56
EX-10.4
from 10-Q
171 pages
Financing Agreement Dated as of August 7, 2020 Among Biohaven Pharmaceutical Holding Company Ltd. and Biohaven Pharmaceuticals, Inc., as Borrowers, the Guarantors From Time to Time Party Hereto, as Guarantors, Various Lenders From Time to Time Party Hereto, and Sixth Street Specialty Lending, Inc., as Administrative Agent
12/34/56
